1. Introduction
Burn injuries pose a significant health threat for individuals and successful treatment of such injuries is crucial for tissue reconstruction. In 2022, the DGV burn register reported 2504 burn cases, with 1787 of the cases involving children [
1]. These injuries can be caused by heat [
2], chemicals [
3], or electricity [
4], and patient treatment methods are constantly being improved. High mortality is observed in patients with complicated wounds, particularly in elderly patients with extensive surface area burns [
5]. These injuries can lead to impaired skin function depending on the severity of the burn. Type IIb and III burns necessitate wound closure and re-epithelialization to restore skin function and minimize scar formation [
6]. Autografting is a commonly used treatment technique, but is reliant on donor skin availability. Skin replacement or skin substitutes can be used to cover the wound bed following a burn injury [
7]. Skin replacements are available in the form of autografts or allografts. Skin substitutes, on the other hand, are a mix of cells or tissues, and can include engineered tissue [
8]. Autografts involve harvesting the patient’s own healthy skin and can be either full-thickness skin grafts (FTSGs) or split-thickness skin grafts (STSGs). The use of the patient’s own skin to cover the wound bed can lead to harvest site infections and the need for a secondary surgical site. Another method used is autologous cell culture, which provides the option to culture and expand the patient’s skin [
9,
10], unlike autografting, which does not increase cells or tissue material. Thus, the use of autologous cell culture is suggested in situations where there is a lack of donor material or when the skin is unsuitable for treatment purposes. The surgical priority is to sufficiently close the wound [
11] and increase patient cell material through autologous cell culture [
12].
Keratinocytes are the primary cell type involved in wound healing and these epithelial cells are essential in the proliferative phase of wound healing [
13]. Keratinocytes are important in re-epithelialization and the restoration of the vascular network [
6]. Clinical studies utilizing cultured autologous keratinocytes have demonstrated rapid re-epithelialization [
14]. Additionally, sprayed autologous cells have shortened hospitalization times, reduced infection risk and yielded better functional and aesthetical outcomes [
12,
15,
16,
17]. Non-cultured epithelial cells can be immediately applied to the wound after biopsy isolation [
18,
19]. Techniques such as spraying cells necessitate the utilization of specialized technical devices to administer the cell suspensions. Cells can be delivered using an aerosol spray. One drawback associated with the use of cultured and non-cultured epithelial autografts is the absence of a dermal component, which is required to support the epidermal layer. However, cultured keratinocytes can be combined with a dermal substitute in the form of an allograft or synthetic mesh [
16,
20]. Keratinocytes can also be combined with tissue glue, such as fibrin [
21]. The use of keratinocytes in burn injuries provides surgeons with a valuable tool for treating patients. However, it is imperative to establish a suitable spray delivery system. Currently, the available spray devices are either bulky or require compressed air or electricity, and may not be particularly easy to handle. Furthermore, the nozzle geometry of the delivery system used can affect the delivery of viable cells [
22]. In this study, the biological effects of three different nozzles were compared to those of the commercially available Cell Spray applicator. Additional high-speed imaging series were conducted to characterize the liquid flow velocity when using different nozzles.
2. Materials and Methods
2.1. Nozzle Types
The Cell Spray applicator (
Supplementary Material Figure S1A), provided by the German Institute for Cell and Tissue Replacement (DIZG gGmbH, Berlin, Germany), uses a 5 mL syringe filled with cell suspension. Airflow occurs via an electric pump, which filters the airflow through a 0.2 μm membrane to prevent contamination. This filtration eliminates airborne bacteria and other particles before they reach the nozzle once airflow commences. Once at the nozzle, the air and suspension mixture form a spray. The fixed airflow rate of this device is 2.4 L/min, with a fixed medium flow rate of 13 mL/min. Alternative nozzle one (AN1) is a commercially available air-assisted nozzle featuring an additional air reservoir port (
Figure S1B). The airflow for this nozzle is powered by an electric pump equipped with an additional flow meter installed for regulating and monitoring the flow rate. Ambient air, before entering the nozzle, undergoes filtration through a 0.2 μm filter membrane. The nozzle can be combined with a Luer-Lock syringe. The second alternative nozzle (AN2) operates without airflow assistance (unassisted) and does not require an airflow system (
Figure S1C). This unassisted nozzle can also be connected to a Luer-Lock syringe. Alternative nozzle three (AN3), also unassisted, comprises a single spray outlet positioned on the nozzle’s side, resulting in a 90-degree spray distribution angle (
Figure S1D). This nozzle required an adapter for adjusting the application direction and was inserted in a Luer-Lock syringe. This adaptation ensured consistent conditions for all nozzles used at the various medium flow rates.
2.2. Spray Distribution Using A4
Different flow rates were used to visualize spray pattern and generate spray images for the different nozzles. This setup was designed to simulate clinical application conditions. Alternative nozzle one was tested using various air and medium flow rates, as shown in
Table 1. The medium flow rates used for AN 2 and 3 were 2.5, 5, 7.5, 10, 13, 15, 20, and 30 mL/min. The applicator used a fixed airflow rate of 2.4 L/min and a medium flow rate of 13 mL/min. A material testing machine was used with a compression test setup. The syringe was positioned below the compression plate of the material testing machine. In a clinical setting, the cell sprayer is moved at a constant speed over the wound for complete coverage. Here, the spraying of cells used an altered agitator that was moved at a constant speed to mimic the clinical settings for wound coverage. An A4 sheet of paper was attached to the agitator’s rotation axis using a cord. With an axis diameter of 3.7 cm, the number of revolutions was adjusted to 103 rotations/min, resulting in a speed of 20 cm/min, which was estimated to correspond to clinical conditions. At the start of the recording, the paper was positioned vertically beneath the sample nozzle. A test medium consisting of cell-free 0.015% methylene blue solution was used to visualize the spray. The longitudinal distribution of the blue test medium, applied with specific flow rates through different nozzles, was recorded on the A4 paper (
Figure 1A). The paper was then dried and scanned using a Kyocera Ecosys scanner (Meerbusch, Germany). Three replicates were generated for each nozzle and flow rate combination. All tubes, syringes, and materials used in the spraying process were sterile.
2.3. Spray Distribution Analysis of A4 Images
The number of particles, mean particle size, overall coverage, and spray amplitude were recorded. ImageJ (1.51.s, National Institute of Health, Bethesda, MD, USA) was used to analyze the scanned images. A pre-installed particle analyzer was used to study particle size and the number of spray droplets, and it classified particles according to their size. Self-designed macros were implemented to determine the spray amplitude and total area coverage. Spray amplitude was defined as 95% of the total blue-colored area. Area coverage was calculated as a percentage difference between colored and non-colored paper.
2.4. Extrusion Force
The constant extrusion rates were determined using a compression test with a material testing machine (Inspekt Table blue 10 kN, Hegewald & Peschke, Nossen, Germany). The syringe was secured on a stable support and placed beneath the compression plate of the machine. The medium flow rate was adjusted to a distance–time function to maintain a constant rate of compression. The force required to extrude the solution was measured using the material testing machine. The maximum and mean extrusion forces were analyzed. The tested medium flow rate and airflow rate were 13 mL/min and 2.4 L/min, respectively. This corresponds to the preset flow rate for the applicator device.
2.5. Cultivation of HaCaT Cells
In vitro assays were conducted to assess the viability, cytotoxicity, and apoptosis of HaCaT cells. The HaCaT cell line was obtained from the BCRT (Berliner Centrum für Reise- und Tropenmedizin), Berlin, Germany in 2014. The cells were stored in liquid nitrogen until use. The cells were passaged in T 175 cm3 cell culture flasks for in vitro testing. Adherent cells were washed with 10 mL PBS and incubated for 17 min at 37 °C with 10 mL 0.05% EDTA solution. Following aspiration of the EDTA solution, cells were detached with 5 mL 0.125% trypsin solution and incubated at 37 °C for 5–7 min. Trypsination was halted by adding 5 mL of medium to the flasks. The cell suspension was filtered through a 40-μm cell strainer to prevent cell aggregates. After centrifugation for 5 min at 300× g, the cells were resuspended in media and counted. A cell number of 3.5 million cells was seeded into T 175 cm3 flasks and cultured at 37 °C with 5% CO2 and Dulbecco’s Modified Eagle Medium (87%), sodium pyruvate (1%), penicillin-streptomycin (1%), L-glutamine (1%), and fetal bovine serum (10%). Approximately two days later, the cells were at 80–90% confluency and ready for the in vitro assays. Sterility was maintained through a combination of aseptic technique, antibiotics, and regular monitoring for contamination.
2.6. Cultivation of Human Donor Keratinocytes
Primary keratinocytes were isolated from human skin for clinical application and patient treatment. Residual keratinocytes, obtained with informed consent for research use, were stored at −80 °C and used for this study. Thawed samples were used for in vitro studies, with NIH-3T3 fibroblasts (DSMZ, Braunschweig, Germany) serving as feeder cells. In culturing primary human keratinocytes, the conventional approach as described by Rheinwald and Green utilizes lethally irradiated mouse fibroblasts (3T3 cells) as a feeder layer to promote keratinocyte adhesion and proliferation [
9]. Once thawed, each vial was treated with 6 mL of enzyme stop medium. Keratinocytes were then centrifuged for 7 min at 200×
g, while murine fibroblasts underwent centrifugation for 4 min at 200×
g. Cells were resuspended, and their number was adjusted for a T 80 cm
3 cell culture flask. A total of approximately 2–3 million keratinocytes and 1.5–2.5 million murine feeder cells were cultivated. Cells were cultured at 37 °C with 5% CO
2 with Dulbecco’s Modified Eagle Medium, Hams F12, FBS, gentamicin, L-glutamine, insulin, choleratoxin, EGF, hydrocortisone, and sodium pyruvate. Feeder cells were removed by trypsination once a confluence of 50% was achieved. Subsequently, cells were washed with 10 mL PBS, the supernatant was removed, and fresh keratinocyte medium was introduced. At 85–90% confluency, in vitro studies were conducted. Confluent cells were washed with 10 mL PBS and trypsinized for 5–7 min with 5 mL of 0.125% trypsin solution. The reaction was stopped using 5 mL enzyme stop solution. Resuspended cells were then filtered through a 40-μm cell strainer for FACS analysis. Suspensions were centrifuged at 200×
g for 7 min and resuspended in media. Cell numbers were determined using trypan blue staining and manually counted with a counting chamber. For the in vitro tests, 1 million cells/mL were used. Sterility was maintained with the use of gentamicin and continuous observation for contamination.
2.7. In Vitro Assays
Cells were transferred into single-use syringes and attached to the different nozzles. The syringes were filled with 1–2 mL of cell suspension and sealed with Luer stopper caps. The cells were then sprayed into 50 mL Falcon tubes using a material testing machine. Viable controls were not sprayed but were instead directly transferred into tubes. All tubes, syringes, and materials used in the spraying process were sterile. Spraying was performed in triplicate for each experimental group with either HaCaT cells or human donor keratinocytes. For human keratinocytes, an alternative nozzle was used in conjunction with the Cell Spray applicator. Three different flow rates were used (10, 20, and 30 mL/min). A 5 mL syringe was used for each flow rate. A viable control and a cytotoxicity control were included. For the cytotoxicity control, 0.1% Triton x-100 solution was mixed with keratinocytes. Cells were then sprayed at the three different flow rates in the same manner as the HaCaT cells.
Four assays were used in this study: the CellTiterGlo Luminescent Assay for viability, the CellTox Green assay for cytotoxicity, and the ApoToxGlo Triplex Assay for viability, cytotoxicity, and apoptosis. These assays are based on different biochemical mechanisms of action. The CellTiterGlo Luminescent Cell Viability Assay relies on the oxidation of luciferin to oxyluciferin, catalyzed by luciferase in the presence of magnesium ions, ATP, and molcular oxygen, which are only produced in viable cells. Oxyluciferin emits a luminescence signal, which can then be detected and quantified. The CellTox Green assay detects cytotoxicity by measuring the binding of CellTox Green to DNA released into the medium, indicating plasma membrane damage. Once bound, a fluorescent signal is generated.
The ApoToxGlo Triplex Assay is a combined assay. Cell viability is detected by a fluorescence signal created by the cleavage of GF-AFC to AFC by protease within the viable cell. Cytotoxicity is also detected by a fluorescence signal. The substrate bis-AAF-R110 is not able to enter live cells but is instead cleaved by the dead-cell protease to release R110, which generates a fluorescent signal. Viability and cytotoxicity are performed simultaneously as they do not affect each other, and measured using different filters for excitation and emission. The apoptosis test is set in the second step of the assay. It relies on the cleavage of a luminogenic substrate containing the DEVD sequence. Following this caspase-3/7 cleavage, a substrate for luciferase is released, resulting in the luciferase reaction and the production of light.
2.8. Viability via Trypan Blue Staining
The viability of the sprayed cell suspension was assessed using trypan blue staining. Cytotoxicity controls were performed in two ways: HaCaT cells were incubated with 25 μmol/L digitonin for 60 min, and primary cells were treated with Triton x-100 as a cytotoxicity control. The cells were then manually counted using the “Cell counter” software tool on ImageJ.
2.9. Viability via Flowcytometry Analysis
A volume of 100 μL of sprayed cell suspension was transferred to each well of a U-bottom 96-well plate and mixed with 150 μL of Live-Dead Staining Solution (Invitrogen, Waltham, MA, USA) per well. Cytotoxicity controls were prepared by incubating HaCaT cells with 25 μmol/L digitonin for 60 min. Primary cells used Triton x-100 as a cytotoxicity control. The plate was then incubated for 20 min at room temperature in the dark. Cell suspensions were analyzed with the BD Acuri Flow cytometer (BD Biosciences, San Jose, CA, USA) using the FL-4 channel.
2.10. Viability of HaCaT Cells
An ApoToxGlo Triplex Assay was used to determine the viability of HaCaT cells after spraying and was performed according to the manufacturer’s guidelines (Promega, Madison, WI, USA). Readouts were taken at 0, 24, and 48 h. Viability is detected using a fluorescence signal that measures GF-AFC cleavage to AFC by protease.
2.11. Viability of Donor Keratinocytes
A RealTime-Glo MT Cell Viability Assay and a CellTox Green Cytotoxicity Assay were used to identify cell viability and cell cytotoxicity for 72 h. These assays were conducted and multiplexed in accordance with the manufacturer’s guidelines (Promega, Madison, WI, USA). The RealTime-Glo assay utilizes the reducing potential of metabolically active cells. A prosubstrate as well as the corresponding luciferase are added to the culture medium. The prosubstrate enters the cells, is reduced to a substrate for the luciferase, and diffuses back into the surrounding medium. The enzyme then converts the substrate, thereby producing a luminescence signal that correlates with the number of metabolically active cells. The reactants of the kits were diluted 1:500 in the according pre-warmed medium and the assay was started by adding 50 μL of reaction mix to each well in order to reach a final dilution of 1:1000 of the reactants. The cells of the cytotoxicity control were sacrificed by adding 4 μL of Lysis Solution (CellTox Green Cytotoxicity Assay Kit) per well. The plate was incubated at 37 °C for 30 min. The fluorescence and luminescence signals were measured after 24, 48, and 72 h of culture using a microplate reader. The fluorescent dye was excited at 485 nm and the signal was measured with an emission filter of 528 nm.
2.12. High-Speed Imaging
Liquid-laser-induced fluorescence (LIF) was used to visualize the structure of the transparent liquid bodies in a spray, such as droplets, blobs, ligaments, and liquid core [
23,
24,
25]. The liquid was pre-enriched with the fluorescent dye fluorescein at a concentration of
. Fluorescence is induced using a continuous wave laser at 447 nm with a maximum power of 3 W. To observe the general shape of the spray, the fluorescence signal was induced by a laser plane with a width of about 25 mm. The incident beam was shaped to obtain an illumination profile as flat as possible and to create a broad light sheet with a thickness of approximately 8 mm (the optical components and their respective arrangement are given in
Figure 1B). Typically, sprays are visualized using shadowgraphy with a fast camera; in this study, LIF high-speed imaging was used to improve spray dynamic observations. Thus, the visualization was conducted with a high-speed camera (Photron SA-X2) running at 100,000 fps and placed in a backscattering configuration. The camera objective was a Nikon Micro-Nikkor with a 105 mm focal length operating at F# = 8. A high-performance fluorescence bandpass filter with a full width at half maximum of 89 nm, centered at 510 nm (Edmund Optics #84-113), was used to detect the fluorescence emission while rejecting the 447 nm scattered light. With this system, the resulting resolution was 38 µm per pixel. AN2 and AN3 were tested at three different injection pressures (high pressure “HP”, medium pressure “MP”, and low pressure “LP”) using the setup described in
Figure 1B. To obtain information on the size of the droplets, Phase Doppler anemometry measurements (@532 nm) were performed at a distance of 30 mm from the nozzle outlet.
2.13. Statistical Methods
Graph Pad Prism 7 (GraphPad Software, Inc., San Diego, CA, USA) was used for the statistical analysis of in vitro tests. A two-way analysis of variance (ANOVA) was performed. Each treated cell mean was compared to the viable control mean. The Dunn’s t-test for multiple comparisons of the groups was linked to the ANOVA. Family-wise significance and the level of confidence were 0.05. For the multiplex assay, significance was calculated using RM 2-way ANOVA. Tukey’s multiple comparison test was used to calculate p-values. Significance is displayed as * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, and **** p ≤ 0.0001. A 95% confidence interval was used.
4. Discussion
Patients suffering from severe dermal disruptions, such as full- or partial-thickness burns, are prone to infections and excessive fluid loss. Restoring the skin’s barrier function, a process known as re-epithelialization, is crucial for healing. Keratinocytes, the primary epidermal cells, play a critical role in successful wound closure [
6]. Cell transplantation, using either sheets or single-cell suspensions, can be performed, but the delivery system significantly impacts re-epithelialization efficiency [
16]. Nozzle type is a critical determinant of cell spray performance. Studies have shown that decreasing nozzle diameter and increasing dispensing pressure can lead to mechanical damage of the cell membrane and loss of cell viability [
31]. Additionally, an in silico nozzle design study informed by experiments has demonstrated that the nozzle geometry, such as nozzle radius, length, and material properties, can all influence cell viability, with shear stress used as a surrogate for cell survival [
22]. The study presented here investigated the delivery of cell suspensions using commercially available nozzles. The tested nozzles exhibited varying effects on spray distribution and cell viability. Wound healing involves cell–cell interactions that drive keratinocyte migration and proliferation [
32]. The applied keratinocytes determine the cell arrangement. Therefore, the spray distribution of a cell spray is expected to impact the homogeneity of the re-epithelialization process. A well-distributed cell suspension is crucial for efficient wound healing and should be carefully considered when designing a cell spray delivery system.
Small droplet size, high particle number, and ample surface coverage are key features of a well-distributed cell spray [
33,
34]. However, studies have shown that aerosol sprays operated at high air pressures negatively impact droplet size and distribution [
35,
36]. Here, particle size, particle number, and surface coverage were shown to depend on the medium flow rate and the nozzle used. For clinical use, spray generated at lower medium flow rates would offer benefits to both the patient and surgeon. By reducing the risk of large droplets carrying away cells, complete wound coverage could be achieved. This would enhance wound healing outcomes by promoting uniform cell distribution and preventing cell aggregation. This is important as the cultivation of keratinocytes takes a long time and only a limited number of cells are available. Additionally, smaller droplets would dry quicker on the wound, potentially penetrating deeper than larger drops and minimizing cell transfer and loss onto the wound dressing. Furthermore, higher particle numbers produced at lower flow rates would provide ample time for surgeons to administer the spray evenly over the entire wound area, ensuring wider coverage and minimal cell clumping.
Using air-assisted nozzles severely impacts cell viability and activity, with higher airflow rates leading to more pronounced reductions in cell survival, metabolic activity, and apoptosis, as shown in
Figure 3B. A significant decrease in metabolic activity and increase in apoptosis were observed for the air-assisted nozzle. This would be in line with the effect that injection pressure can negatively affect viability due to mechanical damage to the cell membrane integrity, leading to a loss in cell viability [
31]. In nozzle-based bioprinting, cell damage mainly comes from shear stress [
37,
38]. Shear stress on the cells can be transduced into a biological signal, ultimately leading to the activation of effector caspases [
39]. Caspases are key regulators of cell death (apoptosis) [
40] and the shear stress on cells may induce the apoptotic pathway. Veazey et al. [
41] reported a viability of 37% when using a nozzle with a small outlet diameter and a high air pressure. In the case of AN1 group 4, the drastic reduction in metabolic activity and apoptosis may be due to the low initial number of viable cells added to the assay, leading to less metabolic activity and cell death (
Figure 3A). In the case of the Cell Spray nozzle, a reduction in metabolic activity was observed. This can be explained by the assay measuring viability relative to the fluorescence of the viable control. This can be supported by the lack of a significantly strong cytotoxic signal in the Cell Spray group; however, this might be due to a lower number of initial cells being transferred. If the cell viability decreases, then it can be assumed that an increase in cytotoxicity or apoptosis occurs; however, this did not happen. The AN1 group 4 showed lower metabolic activity but also showed high cytotoxicity, highlighting that the higher airflow rate may have impacted or damaged the cells. Overall, it can be seen that airflow-assisted nozzles lead to lower metabolic activity and higher cytotoxicity levels. The apoptotic levels for all nozzles seemed to be under 10%. This is considered low and is supported by Amer et al. [
42], who reported low apoptotic values for cells extruded with different needles. This has also been supported by Vernez et al. [
43], who investigated apoptosis levels in cultured epidermal autografts before transplantation, reporting < 6% for the tested autografts. Immediately after spraying, all nozzles displayed a higher cytotoxic effect. This did not appear to continue over a longer period of time, suggesting that the cell membrane may experience shear stress upon spraying with higher airflow rates, displaying significantly higher cytotoxicity. Another important point regarding this assay is that the media is changed every 24 h, thus drastically reducing the cytotoxicity signal present in the medium. The media change will remove any DNA that was previously released into the culture after the cell damage, leading to a reduction in the assay signal. The level of cytotoxicity is of importance due to the possibility of affecting surrounding tissues by dispersing viable and damaged cells. Therefore, minimizing the cytotoxicity after spraying is of importance, especially in a clinical setting, and minimizing any potential harm to surrounding tissues is beneficial to the patients. The unassisted nozzle (AN2) performed very well regarding viability, apoptosis, cytotoxicity, particle size, and overall coverage. AN2 performed either similarly or better than the air-assisted nozzles. The success of AN2, the ability to connect it to a Luer Lock, and the lack of operational requirements such as an auxiliary air reservoir port, make it a suitable nozzle to use. Therefore, when AN2 was combined with the newly designed Cell Spray applicator, it displayed high viability of human donor keratinocytes post-spray, for all flow rates tested. Thus, lower delivery pressures do not affect the survival of donor keratinocytes when using AN2. Fredriksson et al. [
44] compared different application techniques and observed similar results when using similar pressures. They observed a viability of 93.2% for the LINDAL Group nozzle, 84.1% for the Duploject nozzle and 76.6% for the Tissomat at low pressure. The Tissomat displayed lower viability (47.3%) at higher pressures [
44]. Bovine fibroblasts were sprayed by Veazey et al. [
41] at a pressure corresponding to a flow rate between 20 and 30 mL/min. In their study, viabilities of bovine fibroblasts varied from 86 to 94% depending on the nozzle diameter [
41]. This further confirms what was observed with AN2. The real-time assay showed that in the initial 24 h post-spray, a decrease in viability was observed but recovered after 48 h. These findings are similar to that of Harkin et al. [
35], who observed a 30% reduction in viability after 24 h compared to the viable control. Other studies have also shown recovery of cells after the initial 24 h [
36,
45]. The cytotoxicity data were generally higher than what was observed with HaCaT cells. This might be due to the nature of the real-time assay, where the medium is not changed over the period tested. As observed in this study, low-pressure devices seem to lead to better cell survival [
44,
46]. Patients would benefit from this as cell function will be preserved and more viable cells would reach the wound bed, promoting successful grafting. The lower cytotoxicity will also minimize potential harm to surrounding tissues.
Furthermore, the maximum and mean extrusion rates displayed by all the nozzles were well within the maximum human force required to press a syringe. A previous study investigated the forces needed to use a syringe with different needles [
47]. Cilurzo et al. [
47] observed that forces of up to 250 MPa made injection practically impossible, whereas forces lower than 125 MPa led to smooth injection. The needle diameter used in this study was 0.6 mm; therefore, the values can be converted into extrusion forces. A force of 250 MPa is equivalent to 70.75 N, with 160 MPa equaling 45.28 N and 125 MPa equaling 35.37 N. When compared to the study by Cilurzo et al. [
47], all extrusion forces were within the applicable range. During the spraying procedure, a pressure sensor was included to measure the resistance. The pressure sensor recorded an extrusion force ranging from 2–11 N, with most values ranging between 2 and 5 N (
Figure S2).
Several factors influence cell viability and spray capability during the spraying procedure. Extrusion force is crucial and a certain force is needed for proper atomization to achieve a good cone-shaped spray distribution. However, excessively high forces lead to poor atomization, resulting in large, non-uniform droplets instead. Lower forces are ideal for optimal spray formation. Furthermore, high extrusion forces compromise cell viability by increasing shear stress on cells as they pass through the nozzle [
31]. Dispensing pressure, constant pressure rate, and nozzle diameter can also all influence cell viability [
22]. Studies have shown that high cell viscosity and velocity negatively affect viability [
36]. Extrusion force and nozzle geometry impact droplet size, which in turn affects cell viability. Smaller droplets tend to position cells in the center, where shear stress is lower compared to the edges of the spreading film [
36,
48]. Additionally, high droplet velocity can reduce viability due to impact-induced damage [
36]. Numerous factors play a role in cell viability and functionality during spraying. Identifying parameters that minimize these negative effects is crucial.
High-speed imaging provides a valuable tool for use in the medical field. Spray analysis using high-speed imaging demonstrated good spray distribution with an upside-down tulip shape that was apparent when using AN2. Alternative nozzle 3 displayed large droplet sizes compared to AN2 at the same pressure. Moreover, a homogeneous spray pattern was observed for AN2 at higher pressures. Here, high-speed imaging confirms that even when using AN2 at high or maximum pressures, a uniform spread of cells can still be achieved with high viability, as demonstrated with the previously used flow rates. It can also be noted that the AN3 nozzle displayed a bi-modal distribution of the droplet diameter while AN2 displayed a mono-modal distribution. For patient treatment, a mono-modal distribution of sprayed cells would be ideal to maintain an evenly spread healing process.